 Geode Capital Management LLC trimmed its position in shares of BioSpecifics Technologies Corp. NASDAQ:BSTC by 4.1 during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission SEC. The firm owned 91,926 shares of the biopharmaceutical companys stock after selling 3,914 shares during the quarter. Geode Capital Management LLCs ... 